Extendicare (EXE) was up 10% on its Q4 results, which showed continued strength in the home health care segment - with 15% organic volume growth…

… and contribution from its recent $570M acquisition of CTG. Combined with consistent mid-single-digit growth in long-term care, the company’s scale is driving margin expansion…

… which has kept valuation in check, despite a >300% run in shares over the past three years. With an aging population and supply constraints in long-term care…

… Extendicare is well positioned to keep the momentum going.

About Bullpen: Bullpen Finance Inc. publishes content on Canadian markets and provides paid research coverage of select Canadian issuers. Bullpen is paid in cash by covered issuers, does not accept stock or options, does not hold positions in covered securities, and does not conduct investment banking business. Bullpen and LodeRock Advisors Inc. are affiliated; LodeRock provides investor relations services to issuers, some of whom are covered by Bullpen Research. When a post discusses a covered issuer, a specific disclosure appears at the top of the post. This post is published for general information purposes. It is not personalized investment advice and is not tailored to any individual reader’s circumstances. Bullpen is not a registered investment adviser or dealer. For full disclosures, including analyst certification, jurisdictional statements, and conflict of interest policies, please see our Legal & Disclosures section on our website.

You might be interested in…